배아줄기세포를 이용한 연구의 정당성과 관리감독체계 - 인간배아줄기세포연구의 입법 동향을 중심으로 -
A Legitimacy and Management System of Human Embryonic Stem Cell Research - focus on trends in legislation of human embryonic stem cell research -
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Biomedical research is opening new frontiers in treatment of disease,understanding physiological processes, and increasing knowledge. On the other hands, the advance in this field come with a host of ethical quandaries. Yet, this research presents us, as humans, with incredible opportunities to better the lives of almost everyone. Thus, to extent that such research is to be permitted, it should be done under stringent ethical guidelines. Bans or other limitations on embryonic stem cell research do not accomplish their purported goal of saving embryos from destruction. Every year, Thousands of embryos are created through the IVF protocols as part of infertility treatments. Many of these embryos end being destroyed for a variety of reasons. The creation and destruction of these embryos can be ethical, provided that the guiding principle through the entire process remains the best interest of the embryo,thus recognizing the embryo’s humanity. The approach outlined by the present Article allows for a principled support of embryonic stem cell research while acknowledging the humanity of the embryo.
Abstract
Biomedical research is opening new frontiers in treatment of disease,understanding physiological processes, and increasing knowledge. On the other hands, the advance in this field come with a host of ethical quandaries. Yet, this research presents us, as humans, with incredible opportunities to better the lives of almost everyone. Thus, to extent that such research is to be permitted, it should be done under stringent ethical guidelines. Bans or other limitations on embryonic stem cell research do not accomplish their purported goal of saving embryos from destruction. Every year, Thousands of embryos are created through the IVF protocols as part of infertility treatments. Many of these embryos end being destroyed for a variety of reasons. The creation and destruction of these embryos can be ethical, provided that the guiding principle through the entire process remains the best interest of the embryo,thus recognizing the embryo’s humanity. The approach outlined by the present Article allows for a principled support of embryonic stem cell research while acknowledging the humanity of the embryo.
참고문헌 (31)
- 김향미, "배아연구에 관한 법ㆍ윤리적 고찰", 박사, pp.2008
- 박은정, "세계 각국의 줄기세포 연구정책과 규제" (2005), 세창출판사
- 고봉진, "줄기세포주의 국가간 이동", 생명윤리정책연구, 1(1), pp.65~80 (2007), 생명의료법연구소
- 김민중, "인간배아줄기세포연구의 민사법적 의미", 저스티스, (103), pp.5~27 (2008), 한국법학원
- 김옥주, "영국의 줄기세포연구에 관한 윤리와 법정책: 역사적 배경과현황", 생명윤리, 6(1) (2005), 한국생명윤리학회
- 김혁돈, "줄기세포연구와 배아보호", 법학논고, (32), pp.329~353 (2010), 법학연구원
- 박영규, "줄기세포의 윤리적, 경제적 그리고 특허법적 문제", 인권과 정의, (395), pp.98~121 (2009), 대한변호사협회
- 이재목, "바이오의료행위에 있어서 Informed Consent 법리의 적용범위와 한계-인간배아줄기세포의 치료적 연구를 중심으로-", 인권과 정의, (380), pp.109~126 (2008), 대한변호사협회
- 이정현, "생명윤리 및 안전에 관한 법률 전부개정(안)과 바이오뱅크를 이용한연구에서의 피험자 보호방안", 의생명과학과 법, 3 (2010), 원광대학교법학연구소 의생명과학법센터
- 이인영, "인간 배아 보호를 위한 법정책에 관한 고찰", 형사정책연구, 13(3), pp.3~86 (2002), 한국형사정책연구원
- 이인영, "생식세포, 배아에 대한 쟁점사항 및 입법논의", 한국의료법학회지, 17(2), pp.159~194 (2009), 한국의료법학회
- 정차호, "인간배아 줄기세포 연구결과물-인간성과 특허성의 병존모색-", 법학연구, 15(1) (2004), 충남대학교 법학연구소
- 조영미, "산전유전자 진단검사와 여성의 출산 선택권", ELSI연구, 3(1) (2005), KAIST
- 황만성, "난자매매에 대한 형사제재의 정당성과 한계", 한양법학, (21), pp.829~849 (2007), 한양법학회
- Braude P, "Moore S. Human gene expression first occures between the four-and eight-cell stage of preimplantation development" (1998), Nature
- Embryonic Death and the Creation of Human Embryonic Stem Cells, "Donald W. Landry", J. Clinical Investigation, ~ (2004)
- G. Ragini, "The 2004 Italian Legislation Regulating Assisted Reproduction Technology: A Multicenter Survey on the Result of IVF Cycles" (2005), Hum. Reprod
- A defense of embryonic stem sell research, "Gregory Dolin, M.D.", 2009, ~
- H. Gerbert Welch, "Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?", J. Am. Med. Ass'n, 283 (2000)
- M. Lane Molen, "Comment, Recognizing the Larger Sacrifice: Easing the Burdens Borne by Living Organ Donors Through Federal Tax Deductions", BYU J. Pub. L, 21 (2007)
- Moore KL, Persaud, "Clinically Oriented Embryology. 7th ed" (2004), WB Saunders
- Ethical Issue In Human Stem Cell Research, "National Bioethics Advisory Commission", ~ (1999)
- O’Rahilly R, "Human Embryology and Teratology, 3rd ed" (2000), Wiley-Liss
- Oh SK, "Derivation and characterization of new human embryonic stem cell line: SNUhES1, SNUhES2 and SNUhES3" (2005), Stem Cells
- Alternative Sources of Human Pluripotent Stem Cells, "President's Council on Bioethics", ~ (2005)
- Autonomy and Informed Consent in Nontherapeutic Biomedical Research, "Russell Korobkin", UCLA L. Rev, ~ (2007)
- Sharona Hoffman, "Unmanaged Care: Towards Moral Fairness in Health Care Coverage", Ind. L. J, 78 (2003)
- Susan M. Wolf, "Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits", J.L. Med. & Ethics, 31 (2003)
- Thomson JA, "Embryonic stem cell line derived from human blastocysts" (1998), Science
- The World Medical Association Statement on Assisted Reproductive Technologies, "World Med. Ass’n", ~ (2006)
- Zhenyu Ju, "A Dual Role of p21 in Stem Cell Aging" (2007), Annals N. Y. Acad. Sci